Coronavirus disease 2019 ( COVID ‐19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

(2020) Victor M Corman et al.   Eurosurveillance

Reducing mortality from 2019-nCoV: host-directed therapies should be an option

(2020) Alimuddin Zumla et al.   LANCET

Psoriasis, COVID ‐19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment

(2020) M. Magnano et al.   Dermatologic Therapy

Cutaneous manifestations of COVID-19: Report of three cases and a review of literature

(2020) Muskaan Sachdeva et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Should patients stop their biologic treatment during the COVID-19 pandemic

(2020) Arjun M. Bashyam et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Covid-19: risk factors for severe disease and death

(2020) Rachel E Jordan et al.   BMJ-British Medical Journal

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times

(2020) Nicholas D. Brownstone et al.   Dermatology and Therapy